BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

AstraZeneca PLC (AZN) Pays $26 Million to Settle Seroquel Suit


8/27/2012 7:45:50 AM

For the past year, AstraZeneca was aggressively pursuing a strategy to challenge a state lawsuit that relied on the use of private law firms and contingency fee arrangement. Several drugmakers, in fact, adopted this approach in response to state lawsuits that charged various drugs were marketed illegally and state programs and taxpayers overpaid for the medicines. Drugmakers believe the outside law firms have improper incentives and due process rights are jeopardized. Instead of proceeding, however, with one such effort in South Carolina, AstraZeneca has now agreed to pay $26 million to settle the litigation. In this instance, the South Carolina attorney general sought to recover funds spent to treat side-effects for the Seroquel antipsychotic and for reimbursements for alleged off-label uses. Earlier this year, a South Carolina state court judge denied a motion to dismiss a lawsuit that AstraZeneca had filed.

Read at Pharmalot
Read at Chicago Tribune
Read at News Release


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->